CORRESP Filing
VOLITIONRX LTD
Date: July 10, 2025 · CIK: 0000093314 · Accession: 0001477932-25-004973
AI Filing Summary & Sentiment
Reasoning
Letter
vnrx_s3.htm VOLITIONRX LIMITED 1489 West Warm Springs Road, Suite 110 Henderson, Nevada 89014 July 10, 2025 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: VolitionRx Limited’s Acceleration Request Registration Statement on Form S-3 Filed July 3, 2025 File No. 333- 288508 Requested Date : July 14, 2025 Requested Time : 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “ Company ”), hereby respectfully requests that the Securities and Exchange Commission (the “ Commission ”) takes appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable. Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com . We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective. Sincerely, VOLITIONRX LIMITED /s/ Cameron Reynolds Cameron Reynolds President and Chief Executive Officer cc: VolitionRx Limited Terig Hughes, Chief Financial Officer Stradling Yocca Carlson & Rauth LLP Marc G. Alcser, Esq.
Show Raw Text
CORRESP 1 filename1.htm vnrx_s3.htm VOLITIONRX LIMITED 1489 West Warm Springs Road, Suite 110 Henderson, Nevada 89014 July 10, 2025 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: VolitionRx Limited’s Acceleration Request Registration Statement on Form S-3 Filed July 3, 2025 File No. 333- 288508 Requested Date : July 14, 2025 Requested Time : 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “ Company ”), hereby respectfully requests that the Securities and Exchange Commission (the “ Commission ”) takes appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable. Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com . We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective. Sincerely, VOLITIONRX LIMITED /s/ Cameron Reynolds Cameron Reynolds President and Chief Executive Officer cc: VolitionRx Limited Terig Hughes, Chief Financial Officer Stradling Yocca Carlson & Rauth LLP Marc G. Alcser, Esq.